Titles: S.2516 — 112th Congress (2011-2012)All Bill Information (Except Text)

Short Titles:

Short Titles - Senate

Short Titles as Reported to Senate:

Food and Drug Administration Safety and Innovation Act

Short Titles as Reported to Senate for portions of this bill:
  • Biosimilar User Fee Act of 2012
  • Generic Drug User Fee Amendments of 2012
  • Medical Device User Fee Amendments of 2012
  • Prescription Drug User Fee Amendments of 2012

Short Titles as Introduced:

Food and Drug Administration Safety and Innovation Act

Short Titles as Introduced for portions of this bill:
  • Biosimilar User Fee Act of 2012
  • Generic Drug User Fee Amendments of 2012
  • Medical Device User Fee Amendments of 2012
  • Prescription Drug User Fee Amendments of 2012

Official Titles:

Official Titles - Senate

Official Titles as Introduced:

An original bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes.